FDA slaps a clinical hold on messenger RNA program for rare genetic disease

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 22, 2019 at 12:22: PM
via Translate Bio’s plans to put a second messenger RNA drug in the clinic in the first half of 2019 has just ground to a halt in front of a sudden regulatory red light.

article source
 

<



Similar threads

cafead
FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test
Replies
0
Views
281
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bad to worse for Applied Therapeutics as FDA slaps partial clinical hold on rare drug
Replies
0
Views
193
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
Replies
0
Views
164
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA slaps hold on DBV peanut allergy trial in call for protocol changes
Replies
0
Views
199
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA slaps hold on Finch&#039;s C. diff med to get info on COVID-19 screening for...
Replies
0
Views
223
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote